original ) (raw )ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementia
Dilip Jeste , Dan Blazer
Neuropsychopharmacology, 2008
View PDFchevron_right
Pharmacological Treatment of Psychosis and Agitation in Elderly Patients with Dementia
Anne Bailey
Drugs & Aging, 2002
View PDFchevron_right
Paradoxical side effect in treatment with antipsychotics for aggression/agitation and psychosis in dementia: case-series
Tudor Florea
BULLETIN OF INTEGRATIVE PSYCHIATRY, 2020
View PDFchevron_right
Rethinking antipsychotic use in dementia: a literature review on efficacy, safety, and alternatives
Omar Basubrain
2024
View PDFchevron_right
A Systematic Review of the Efficacy and Safety of Atypical Antipsychotics in Patients with Psychological and Behavioral Symptoms of Dementia
Kim Peterson
Journal of the American Geriatrics Society, 2006
View PDFchevron_right
Antipsychotics in Alzheimer's disease: A critical analysis
Eduardo Marques da Silva
Dementia & Neuropsychologia, 2011
View PDFchevron_right
Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review
Philip Lee
BMJ, 2004
View PDFchevron_right
Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer's Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial
jeffrey lieberman
American Journal of Psychiatry, 2008
View PDFchevron_right
Novel Antipsychotics in the Treatment of Psychosis and Aggression Associated With Dementia: A Meta-Analysis of Randomized Controlled Clinical Trials
karla _ Alrak Soares
International Psychogeriatrics, 2000
View PDFchevron_right
Antipsychotics in Alzheimer's disease
Eduardo Marques da Silva
2011
View PDFchevron_right
Antidepressants for agitation and psychosis in patients with dementia
quynh bui
American family physician, 2012
View PDFchevron_right
Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease
jeffrey lieberman
New England Journal of Medicine, 2006
View PDFchevron_right
Role of antipsychotics for treating behavioral and psychological symptoms of dementia
Kai Zhen Yap
World Journal of Pharmacology, 2014
View PDFchevron_right
A Narrative Review of Studies Comparing Efficacy and Safety of Citalopram with Atypical Antipsychotics for Agitation in Behavioral and Psychological Symptoms of Dementia (BPSD)
Maree Donna Simpson
Pharmacy
View PDFchevron_right
Prescribing patterns for psychotic and behavioural symptoms in dementia: a national survey
Elizabeth Brooks
Psychiatric Bulletin, 2002
View PDFchevron_right
Alternative pharmacological treatment options for agitation in Alzheimer’s disease
B. Imbimbo
Geriatric Care, 2015
View PDFchevron_right
The treatment of behavioral disturbances and psychosis associated with dementia
Gerald Maguire
Psychiatria Polska, 2016
View PDFchevron_right
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer Disease Trial Methodology
Sonia Davis
American Journal of Geriatric Psychiatry, 2001
View PDFchevron_right
Antipsychotics for behavioral and psychiatric symptoms of dementia: a reaudit in a specialist inpatient service
Camilla Haw
International Psychogeriatrics, 2014
View PDFchevron_right
Antipsychotic Agents in Patients with Dementia
M. Crismon
Pharmacotherapy, 2000
View PDFchevron_right
Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis
Phatchara Jongsomboonphoka
View PDFchevron_right
Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis
Tzung-Jeng Hwang
Journal of the Formosan Medical Association, 2015
View PDFchevron_right
Elderly Patients With Dementia-Related Symptoms of Severe Agitation and Aggression: Consensus Statement on Treatment Options, Clinical Trials Methodology, and Policy
George Grossberg
The Journal of Clinical Psychiatry, 2008
View PDFchevron_right
Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes
Gayan Perera
European Journal of Epidemiology, 2020
View PDFchevron_right
Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis
Itthipol Tawankanjanachot
British journal of clinical pharmacology, 2018
View PDFchevron_right
Use and safety of antipsychotics in behavioral disorders in elderly people with dementia
Pietro Gareri
Journal of Clinical Psychopharmacology, 2014
View PDFchevron_right
Antipsychotic Use in Dementia
Colleen Maxwell
The Canadian Journal of Psychiatry, 2016
View PDFchevron_right
Antipsychotics Versus Cholinesterase Inhibitors for the Treatment of Psychosis in Alzheimer’s Disease: A Critical Review
Howard Margolese
2012
View PDFchevron_right
Progresses in treating agitation: a major clinical challenge in Alzheimer's disease
B. Imbimbo
Expert opinion on pharmacotherapy, 2015
View PDFchevron_right
Don't use antipsychotics routinely to treat agitation and aggression in people with dementia
Anne Corbett
BMJ (Clinical research ed.), 2014
View PDFchevron_right
Association between antipsychotics and adverse outcomes in dementia
Sheliza Samnani
Progress in Neurology and Psychiatry, 2017
View PDFchevron_right
Treatment of agitation in dementia
Anton Porsteinsson
New directions for mental health services, 1997
View PDFchevron_right
Use of atypical antipsychotic drugs in patients with dementia
Timothy Lacy
American Family Physician, 2003
View PDFchevron_right